Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sofia Bezati, Antonios Boultadakis, Ioannis Ventoulis, Eftihia Polyzogopoulou & John T. Parissis. (2023) Optimal use of intravenous landiolol in acute cardiac care. Expert Review of Cardiovascular Therapy 21:11, pages 855-866.
Read now
Read now
Articles from other publishers (4)
Sebastian Schnaubelt, Felix Eibensteiner, Julia Oppenauer, Daniel Tihanyi, Marco Neymayer, Roman Brock, Andrea Kornfehl, Christoph Veigl, Valentin Al Jalali, Sonja Anders, Barbara Steinlechner, Hans Domanovits & Patrick Sulzgruber. (2023) Hemodynamic and Rhythmologic Effects of Push-Dose Landiolol in Critical Care—A Retrospective Cross-Sectional Study. Pharmaceuticals 16:2, pages 134.
Crossref
Crossref
Valentina Ditali, Laura Garatti, Nuccia Morici, Luca Villanova, Claudia Colombo, Fabrizio Oliva & Alice Sacco. (2021) Effect of landiolol in patients with tachyarrhythmias and acute decompensated heart failure (ADHF): a case series. ESC Heart Failure 9:1, pages 766-770.
Crossref
Crossref
Geoffroy Hariri, Tomas Urbina, Sandie Mazerand, Naike Bige, Jean-Luc Baudel & Hafid Ait-Oufella. (2021) Rate control in atrial fibrillation using Landiolol is safe in critically ill Covid-19 patients. Critical Care 25:1.
Crossref
Crossref
Akihiro Yokoyama, Motohiro Sekino, Taiga Ichinomiya, Hironori Ishizaki, Keiko Ogami-Takamura, Takashi Egashira, Rintaro Yano, Sojiro Matsumoto, Ushio Higashijima & Tetsuya Hara. (2021) Anaphylactic shock in a patient with severe aortic stenosis treated with adrenaline and landiolol for circulatory management. Medicine 100:35, pages e27135.
Crossref
Crossref